Article FDA Thank You FDA updates guidance on developing drugs for Covid-19, replacing pandemic-era version
Agency IQ
DECEMBER 1, 2023
FDA’s guidance on developing products to prevent or treat Covid-19 Of the five guidance documents that received an extension, one addresses the development of drugs and biological products for Covid-19. For such studies, the FDA recommended a primary endpoint of laboratory-confirmed SARS-CoV-2 infection with or without symptoms.
Let's personalize your content